Platelets: the next-generation ovarian cancer biomarker?

Amelia Janiak; Vahid Afshar-Kharghan; David G. Menter; Anil K. Sood; Sara Corvigno

doi:10.1016/j.trecan.2026.03.005

Platelets: the next-generation ovarian cancer biomarker?

Research output: Contribution to journal › Short survey › peer-review

Abstract

The diagnosis and monitoring of ovarian cancer remain major clinical challenges due to nonspecific symptoms, late-stage detection, and high rates of recurrence. Increasing evidence suggests that circulating platelets reflect tumor presence and activity. Platelet-based molecular and functional signatures may, therefore, represent a promising new class of biomarkers for ovarian cancer.

Original language	English (US)
Pages (from-to)	477-480
Number of pages	4
Journal	Trends in Cancer
Volume	12
Issue number	6
DOIs	https://doi.org/10.1016/j.trecan.2026.03.005
State	Published - Jun 2026

Keywords

cancer biomarkers
liquid biopsy
ovarian cancer
platelets

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/j.trecan.2026.03.005

Cite this

@article{9885d79a57da497f9ce5bbc8ed6fc504,

title = "Platelets: the next-generation ovarian cancer biomarker?",

abstract = "The diagnosis and monitoring of ovarian cancer remain major clinical challenges due to nonspecific symptoms, late-stage detection, and high rates of recurrence. Increasing evidence suggests that circulating platelets reflect tumor presence and activity. Platelet-based molecular and functional signatures may, therefore, represent a promising new class of biomarkers for ovarian cancer.",

keywords = "cancer biomarkers, liquid biopsy, ovarian cancer, platelets",

author = "Amelia Janiak and Vahid Afshar-Kharghan and Menter, \{David G.\} and Sood, \{Anil K.\} and Sara Corvigno",

note = "Publisher Copyright: {\textcopyright} 2026 Elsevier Inc.",

year = "2026",

month = jun,

doi = "10.1016/j.trecan.2026.03.005",

language = "English (US)",

volume = "12",

pages = "477--480",

journal = "Trends in Cancer",

issn = "2405-8033",

publisher = "Cell Press",

number = "6",

}

TY - JOUR

T1 - Platelets

T2 - the next-generation ovarian cancer biomarker?

AU - Janiak, Amelia

AU - Afshar-Kharghan, Vahid

AU - Menter, David G.

AU - Sood, Anil K.

AU - Corvigno, Sara

PY - 2026/6

Y1 - 2026/6

N2 - The diagnosis and monitoring of ovarian cancer remain major clinical challenges due to nonspecific symptoms, late-stage detection, and high rates of recurrence. Increasing evidence suggests that circulating platelets reflect tumor presence and activity. Platelet-based molecular and functional signatures may, therefore, represent a promising new class of biomarkers for ovarian cancer.

AB - The diagnosis and monitoring of ovarian cancer remain major clinical challenges due to nonspecific symptoms, late-stage detection, and high rates of recurrence. Increasing evidence suggests that circulating platelets reflect tumor presence and activity. Platelet-based molecular and functional signatures may, therefore, represent a promising new class of biomarkers for ovarian cancer.

KW - cancer biomarkers

KW - liquid biopsy

KW - ovarian cancer

KW - platelets

UR - https://www.scopus.com/pages/publications/105035638044

UR - https://www.scopus.com/pages/publications/105035638044#tab=citedBy

U2 - 10.1016/j.trecan.2026.03.005

DO - 10.1016/j.trecan.2026.03.005

M3 - Short survey

C2 - 41991387

AN - SCOPUS:105035638044

SN - 2405-8033

VL - 12

SP - 477

EP - 480

JO - Trends in Cancer

JF - Trends in Cancer

IS - 6

ER -

Platelets: the next-generation ovarian cancer biomarker?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this